Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Summary

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. PURPOSE: This randomized phase I trial is studying the side effects and best dose of photodynamic therapy in treating patients with premalignant or early stage head and neck tumors.

Timeline

Start

2009-01

Primary completion

2016-11

Completion

2016-11

Drugs

Indications